ADVM—Just listened to the relevant portion of the CC, which starts at 1:09:45 (https://edge.media-server.com/mmc/p/ap5329mf ). I think this issue, which was raised by @sentivcapital on Twitter, is a false alarm. The doctor on the webcast is saying that steroid usage is generally not a concern in patients who are pseudophakic—he is not referring to patients in ADVM's trial.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.